GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » Forward PE Ratio

Sinopharm Tech Holdings (HKSE:08156) Forward PE Ratio : 0.00 (As of Jun. 09, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings Forward PE Ratio?

Sinopharm Tech Holdings's Forward PE Ratio for today is 0.00.

Sinopharm Tech Holdings's PE Ratio without NRI for today is 0.33.

Sinopharm Tech Holdings's PE Ratio for today is 0.00.


Sinopharm Tech Holdings Forward PE Ratio Historical Data

The historical data trend for Sinopharm Tech Holdings's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings Forward PE Ratio Chart

Sinopharm Tech Holdings Annual Data
Trend
Forward PE Ratio

Sinopharm Tech Holdings Quarterly Data
Forward PE Ratio

Competitive Comparison of Sinopharm Tech Holdings's Forward PE Ratio

For the Software - Application subindustry, Sinopharm Tech Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's Forward PE Ratio Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's Forward PE Ratio falls into.



Sinopharm Tech Holdings Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Sinopharm Tech Holdings  (HKSE:08156) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Sinopharm Tech Holdings Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings (HKSE:08156) Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines